BIOCON
Back to Cashflow Statement
|
BIOCON Last 5 Year Cash Flow from Operating Activities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Cash Flow from Operating Activities | ₹2,954 Cr | ₹1,853 Cr | ₹1,177 Cr | ₹1,160 Cr | ₹1,283 Cr |
What is the latest Cash Flow from Operating Activities ratio of BIOCON ?
Year | Cash Flow from Operating Activities |
---|---|
Mar2024 | ₹2,954 Cr |
Mar2023 | ₹1,853 Cr |
Mar2022 | ₹1,177 Cr |
Mar2021 | ₹1,160 Cr |
Mar2020 | ₹1,283 Cr |
How is Cash Flow from Operating Activities of BIOCON Trending?
Years | Cash Flow from Operating Activities | % Change | |
---|---|---|---|
Mar2024 | ₹2,954 Cr | 59.45 | |
Mar2023 | ₹1,853 Cr | 57.45 | |
Mar2022 | ₹1,177 Cr | 1.46 | |
Mar2021 | ₹1,160 Cr | -9.62 | |
Mar2020 | ₹1,283 Cr | - |
Compare Cash Flow from Operating Activities of peers of BIOCON
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
BIOCON | ₹36,642.3 Cr | -11.7% | -8.5% | 19.1% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹396,394.0 Cr | -6.7% | 2.6% | 5% | Stock Analytics | |
DIVIS LABORATORIES | ₹142,920.0 Cr | -6.6% | -3.7% | 43.8% | Stock Analytics | |
CIPLA | ₹114,383.0 Cr | -5.3% | -2.9% | -1.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹105,817.0 Cr | -3.8% | 1.8% | 25.8% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹91,385.4 Cr | -4.9% | -3.3% | -10.2% | Stock Analytics |
BIOCON Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
BIOCON | -11.7% |
-8.5% |
19.1% |
SENSEX | -3.6% |
-0.7% |
-0.5% |
You may also like the below Video Courses